Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study
Life · 22.04.2026 · 16 (5) · 708
DOI: 10.3390/life16050708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 22.04.2026. Verfasst von Humera Banu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Deanship at University of Ha'il-Saudi Arabia, University of Ha’il.
Abstract (Originalsprache)
This study aims to investigate the potential anticancer effects of erucin, an isothiocyanate derived from Eruca sativa, in triple-negative breast cancer (TNBC) by predicting molecular targets and evaluating its in vitro effects on TNBC cell proliferation, apoptosis and cell cycle distribution. Potential protein targets of erucin were identified using SwissTargetPrediction, resulting in 117 targets, of which 84 overlapped with TNBC-related genes sourced from GeneCards, DisGeNET, and OMIM. Protein–protein interaction analysis was performed to identify key hub genes. In vitro experiments were conducted using MDA-MB-231 TNBC cells to assess dose-dependent effects on cell viability. Flow cytometry was employed to evaluate apoptotic cell populations and cell cycle distribution. Protein–protein interaction analysis identified ten hub genes, including AKT1, STAT3, EGFR, and MMP9, representing highly connected nodes within the predicted interaction network. In vitro studies showed dose-dependent reduction in MDA-MB-231 cell viability following erucin treatment, with an IC50 of approximately 48.87 µg/mL. Flow cytometry revealed increased apoptotic cell population and G1 phase accumulation. These findings suggest that erucin is associated with cytotoxic and antiproliferative effects in TNBC cells and may interact with multiple cancer-related targets. However, the identified molecular targets and pathways are based on computational predictions and require further experimental validation. Overall, this study provides a preliminary integrated framework linking computational predictions with experimental observations, which may support future mechanistic and preclinical investigations of erucin in TNBC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Nutrition, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.
- Department of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, Ha'il 55476, Saudi Arabia.
- Medical and Diagnostic Research Center, University of Ha'il, Ha'il 55473, Saudi Arabia.
- Department of Bioinformatics, Faculty of Engineering and Technology, Marwadi University, Rajkot 360003, Gujarat, India.
- Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.
- Department of Physical Therapy, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.
ORCID-Profile: Humera Banu, Eyad Al Shammari, Husam Qanash, Mitesh Patel, Mohd Adnan, Mohammad Idreesh Khan, Syed Amir Ashraf
Förderung
- Scientific Research Deanship at University of Ha'il-Saudi Arabia
- University of Ha’il
Zitieren
APA
Banu, H., Shammari, E. A., Qanash, H., Patel, M., Adnan, M., Shahanawaz, S., Khan, M. I., Qattan, M. Y., & Ashraf, S. A. (2026). Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study. Life, 16(5), 708. https://doi.org/10.3390/life16050708
Vancouver
Banu H, Shammari EA, Qanash H, Patel M, Adnan M, Shahanawaz S, et al. Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study. Life. 2026;16(5):708. doi:10.3390/life16050708
BibTeX
@article{Banu2026,
author = {Banu, Humera and Shammari, Eyad Al and Qanash, Husam and Patel, Mitesh and Adnan, Mohd and Shahanawaz, Syed and Khan, Mohammad Idreesh and Qattan, Malak Yahia and Ashraf, Syed Amir},
title = {Erucin Targets Oncogenic Signaling Pathways in Triple-Negative Breast Cancer: An Integrated Network Pharmacology and In Vitro Study},
journal = {Life},
year = {2026},
volume = {16},
number = {5},
pages = {708},
doi = {10.3390/life16050708}
}
EUVIMED